Boardroom Alpha
Research library
SPACs · Nov 20, 2026

SPAC Market Update November 20, 2026: TDAC-ProLogium $3.9B Amendment

Translational Development Acquisition Corp. (TDAC) and ProLogium amended their merger agreement on November 20, 2026, setting a $3.9 billion equity value and post-closing governance terms. Separately, TDAC corrected proposed investment commitments from $85…

SPAC IPO Update — November 20, 2026

No SPAC IPOs priced on November 20, 2026.

SPAC IPO Count

Monthly IPOs (last 13 months)
Latest: 0•Prior: 6•MoM: -6
10
Nov ’25
22
Dec ’25
24
Jan ’26
27Peak
Feb ’26
11
Mar ’26
16
Apr ’26
20
May ’26
19
Jun ’26
18
Jul ’26
12
Aug ’26
5
Sep ’26
6
Oct ’26
0
Nov ’26
Source: Boardroom Alpha
IPO Activity SnapshotMonth-to-date: 0 IPOs ($0.0M) vs. first 20 days of last month 4 ($491M) · 12-mo avg: 16/mo
New SPAC IPOs
Date Ticker Issuer IPO Size Trust Funding
Source: Boardroom Alpha

Daily SPAC Update — November 20, 2026

SPAC VOTE RESULTS
AIMEI HEALTH TECHNOLOGY CO LTD (AFJK) * Extend to December 6, 2027841,629 redeemed · $10,377,286 removed · trust $12.33

SPAC DEAL & EXTENSION VOTES SET
Alphatime Acquisition Corp (ATMC) * EXTENSION VOTE SET: December 2, 2026 * trust $11.87

EXTENSION VOTES
FACT II ACQUISITION CORP (FACT)vote November 17, 2026 -> extend from November 27, 2026 to November 25, 2027
JACKSON ACQUISITION CO II (JACS)vote November 20, 2026 -> extend from December 11, 2026 to December 11, 2027

SPAC EXTENSIONS
QUARTZSEA ACQUISITION CORP (QSEA) * Extension FilingQuartzsea deposited $100,000 into its trust account, extending its business-combination deadline by one month to December 19, 2026.

OTHER SPAC NEWS
FACT II ACQUISITION CORP (FACT) * Trust Update * trust $10.83
FG IMPERII ACQUISITION CORP (FGII) * Forward Purchase AgreementFG Imperii and tZERO arranged a prepaid share forward with an insider-affiliated seller for up to 2.5 million combined-company shares, creating potential dilution but no closing cash proceeds.
INFLECTION POINT ACQUISITION CORP VII (IPXG) * Media TranscriptElroy Air CEO Andrew Clare outlined Chaparral’s capabilities, commercial and defense demand, production plans, and the rationale for its proposed public-market transaction.
SIZZLE ACQUISITION CORP II (SZZL) * Investor Deck
TRANSLATIONAL DEVELOPMENT ACQUISITION CORP (TDAC) * Merger Agreement AmendmentProLogium and TDAC amended their merger agreement, setting a $3.9 billion equity value and establishing recapitalization, voting-control, and post-closing board terms.
TRANSLATIONAL DEVELOPMENT ACQUISITION CORP (TDAC) * PIPE UpdateProLogium corrected proposed investment commitments tied to its TDAC merger from $85 million to up to $135 million, at $10 per share.

SPAC DEALS ANNOUNCED
November 18 | American Drive Acquisition Co (ADAC) + Simpler Postage, Inc.
November 17 | Berto Acquisition Corp (TACO) + Ampera, Inc.
November 17 | Stellar V Capital Corp (Cayman Islands) (SVCC) + Turquoise Group Pty LtdTurquoise Group Pty Ltd is an Australian company that focuses on producing synthetic graphene through a proprietary plasma methane-pyrolysis manufacturing process. It operates a commercial demonstration plant in Darra, Australia, with a capacity of 30 tons per annum (tpa) and plans to expand this capacity to 60 tpa. The company aims to construct additional facilities in Australia, the USA, and Vietnam, each with a capacity of 300 tpa, pending regulatory approvals.
November 16 | Wen Acquisition Corp (WENN) + Our Next Energy IncOur Next Energy Inc is an American battery company that designs and manufactures lithium iron phosphate (LFP) battery cells, packs, battery management systems, and energy storage systems. It serves end markets including defense, rail, and grid applications. Founded in 2020 and headquartered in Novi, Michigan, it operates two manufacturing facilities in the state.

SPAC Movers — November 20, 2026

YESTERDAY’S TOP SPAC GAINERS
Company Ticker Change Price Stage
RIBBON ACQUISITION CORP RIBB 7.7% $ 7.91 Announced
GP-ACT III ACQUISITION CORP GPAT 2.9% $ 11.70 Announced
TCGX ACQUISITION CORP II TCXB 2.4% $ 10.40 Pre-Deal
CALISA ACQUISITION CORP ALIS 1.8% $ 8.72 Announced
VELOS ACQUISITION I CORP VLOS 1.7% $ 10.90 Pre-Deal
YESTERDAY’S TOP SPAC LOSERS
Company Ticker Change Price Stage
BLACK HAWK ACQUISITION CORP BKHA -24.7% $ 6.48 Announced
INFLECTION POINT ACQUISITION CORP VI IPFX -7.1% $ 9.99 Announced
MELAR ACQUISITION CORP I MACI -1.8% $ 8.20 Announced
BEST SPAC I ACQUISITION CORP BSAA -1.4% $ 10.48 Announced
YHN ACQUISITION I LTD YHNA -1.1% $ 11.00 Announced
Source: Boardroom Alpha market data

Frequently Asked Questions

  • What did the TDAC-ProLogium merger amendment set?
    Translational Development Acquisition Corp. (TDAC) and ProLogium set a $3.9 billion equity value and established recapitalization, voting-control and post-closing board terms.
  • How did ProLogium’s proposed TDAC investment commitments change?
    The company corrected proposed commitments tied to the TDAC merger from $85 million to up to $135 million, with securities priced at $10 per share.
  • How much did AFJK redeem at its extension vote?
    Aimei Health Technology Co Ltd (AFJK) had 841,629 shares redeemed, removing $10,377,286 from trust at $12.33 per share; the extension runs to December 6, 2027.
  • When is ATMC‘s extension vote scheduled?
    Alphatime Acquisition Corp (ATMC) set its extension vote for December 2, 2026. It was the only extension vote scheduled today.
  • How did QSEA extend its deadline?
    Quartzsea Acquisition Corp (QSEA) deposited $100,000 into trust, extending its business-combination deadline by one month to December 19, 2026.


Get it in your inbox

The Daily SPAC Update in your inbox

Every IPO, vote, and DeSPAC close — analyzed daily for finance professionals.

ShareXLinkedIn

Published Nov 20, 2026

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer